(Q46941551)

26 December 2017

title

Large-scale monocyte enrichment coupled with a closed culture system for the generation of human dendritic cells (English)

1 reference

26 December 2017

1 reference

Vinod Pullarkat

1

1 reference

26 December 2017

Roy Lau

2

1 reference

26 December 2017

Sun-Min Lee

3

1 reference

26 December 2017

James G Bender

4

1 reference

26 December 2017

Jeffrey S Weber

5

1 reference

26 December 2017

publication date

1 September 2002

1 reference

26 December 2017

Journal of Immunological Methods

published in

1 reference

26 December 2017

volume

267

1 reference

26 December 2017

issue

2

1 reference

26 December 2017

page(s)

173-183

1 reference

26 December 2017

Immunobiology of dendritic cells

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900181-3

A controlled comparison of two different clinical grade devices for CD34+ cell selection of autologous blood stem cell grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900181-3

In vitro generation of dendritic cells from human blood monocytes in experimental conditions compatible for in vivo cell therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900181-3

Distinct subsets of dendritic cells resembling dermal DCs can be generated in vitro from monocytes, in the presence of different serum supplements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900181-3

In vitro production of dendritic cells from human blood monocytes for therapeutic use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900181-3

Modulation of T cell production of interferon-gamma by human monocytes: effect of engagement of CD14 on monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900181-3

Ex vivo generation of dendritic cells from CD34+ cells in gas-permeable containers under serum-free conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900181-3

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900181-3

Dendritic cells: specialized and regulated antigen processing machines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900181-3

The molecular basis of CD1-mediated presentation of lipid antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900181-3

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900181-3

Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900181-3

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900181-3

Comparison of monocyte enrichment by immuno-magnetic depletion or adherence for the clinical-scale generation of DC

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900181-3

Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900181-3

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900181-3

Autologous human dendriphages pulsed with synthetic or natural tumor peptides elicit tumor-specific CTLs in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900181-3

Participation of CD1 molecules in the presentation of bacterial protein antigens in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900181-3

Development of a closed-system process for clinical-scale generation of DCs: evaluation of two monocyte-enrichment methods and two culture containers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900181-3

10.1016/S0022-1759(02)00181-3

7 January 2021

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017